Top Cancer Stocks in Japan
Browse the largest Japan companies in the world ranked by their Market Capitalization. Global Cancer Companies in Japan market cap is $441.19M.
30 Jan 2025, 01:06 UTC
Companies: 9
🇯🇵1 | $3.48 | 6.84% | 108.68M | 95.36% | Outperform S&P500 YTD Benchamark | 💊 Pharma | - | |
🇯🇵2 | $5.65 | 2.78% | 84.66M | -7.31% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇯🇵3 | $1.00 | 0.00% | 43.23M | -24.15% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇯🇵4 | $3.63 | 3.63% | 42.98M | -7.90% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇯🇵5 | $0.23 | -2.70% | 38.55M | -21.74% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - | |
🇯🇵6 | $0.15 | 0.00% | 31.85M | 0.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇯🇵7 | $1.72 | -1.46% | 29.46M | -47.27% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇯🇵8 | $4.07 | 0.31% | 29.07M | -35.58% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - | |
🇯🇵9 | $0.27 | 0.00% | 17.21M | -50.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |